Wednesday's top analyst upgrades and downgrades included Coterra Energy, EOG Resources, FedEx, Fortinet, Hertz Global, Palo Alto Networks, Range Resources, Stem, TechnipFMC, Twilio and United Parcel Service.
Wednesday's additional top analyst upgrades and downgrades included CF Industries, Cognex, Incyte, PayPal, XPeng and Xylem.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Airbnb, Block, Caesars Entertainment, CarMax, Lyft, Nike, Paramount Global, S&P Global and Starbucks.
Here is another look at Exelon, Incyte and other stocks that Wall Street analysts expected little from in this past week.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Enphase Energy, General Motors, Incyte, Lyft, MP Materials, Newmont, Tenet Healthcare and Vale.
Here is a look at five stocks that traded up and five that traded lower in Tuesday's premarket session.
Wednesday's top analyst upgrades and downgrades included Activision Blizzard, Electronic Arts, Foot Locker, Incyte, Intel, Las Vegas Sands, LyondellBasell Industries, Nike, SoFi Technologies and Unity Software.
JMP Securities has come out with a few stock picks that it thinks will outperform in the coming months.
Tuesday's top analyst upgrades and downgrades included Bank of New York Mellon, Cloudflare, Consolidated Edison, Ford, IBM, Incyte, Simon Properties and Skechers.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including in Barrick, Nordstrom, Lyft and Twitter.
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List…
Wednesday's top analyst upgrades and downgrades included AECOM, AIG, Dow, DuPont, KLA, Newmont, PG&E, Pinterest, Shake Shack, Snap and Vornado Realty Trust.
Wednesday's top analyst upgrades and downgrades included Alphabet, Advanced Micro Devices, Corning, FireEye, Inovia Pharmaceuticals, Lululemon Athletica, Nike, Roku, Starbucks, Tyson Foods and Walmart.
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover candidates.
Thursday's top analyst upgrades, downgrades and initiations included Alibaba, Annaly Capital Management, Bed Bath & Beyond, Clorox, CrowdStrike, FireEye, GoPro, Lyft, Square, Tesla and Uber Technology.
